Why Medtronic Plc (MDT) stock moved
No significant move on Nov 16, 2026 (+0.0%, close-to-close). Latest notable session: Nov 4, 2026.
Why Medtronic plc (MDT) rose 6.1% on November 4, 2026
Medtronic plc (MDT) rose 6.1% on November 4, 2026, closing at $104.96 versus $98.88 the prior session (close-to-close, from daily closes). Following completion of its MiniMed Split-Off and share retirement program, which retired approximately 55 million shares through an oversubscribed exchange offer without cash outlay (247wallst.com, Yahoo Finance). The move adds ~$6 billion to market value and structurally reduces share count to boost future EPS while refocusing the company on higher-margin core medical device business. Source: 247wallst.com.
Medtronic surged +6.24% to $105.05 following completion of its MiniMed Split-Off and share retirement program, which retired approximately 55 million shares through an oversubscribed exchange offer without cash outlay (247wallst.com, Yahoo Finance). The move adds ~$6 billion to market value and structurally reduces share count to boost future EPS while refocusing the company on higher-margin core medical device business. Volume of 5.4M shares ran at 0.47x the expected pace for this point in the session, suggesting concentrated participation.
What to watch next: Medtronic earnings on November 17, 2026 (consensus EPS estimate $1.33); any post-separation guidance or commentary on organic growth trajectories and margin expansion.
Earlier sessions that moved MDT
- +2.8%Driven by positive real-world clinical data for its cardiovascular portfolio—including strong results from the Sphere-9 catheter and PulseSelect Pulsed Field Ablation systems—combined with completion of the MiniMed separation and retirement of approximately 55 million shares, which boosts future EPS (Motley Fool, Nov.
- +3.8%Medtronic announced positive real-world registry results for its Sphere-9™ catheter and PulseSelect™ PFA System at the APHRS 2026 conference (PR Newswire), driving a +2.72% intraday gain to $95.56.
- +3.9%Medtronic's stock-for-stock exchange offer for MiniMed Group was oversubscribed based on preliminary results.
- +2.6%Driven by a Barclays upgrade to Hold and announcement of the final exchange ratio (4.5939) for the MiniMed Group, Inc. split-off ahead of the October 9 offer expiration, per the web catalyst.
- −2.7%Medtronic PLC (MDT) shares are trading lower today, down -2.20% to $87.53 in late morning trading.The primary catalysts driving the downward pressure include: - Ex-Dividend Date Adjustments : Medtronic's recently declared dividend of $0.72 per share had its ex-dividend date set for September 25.
Medtronic Plc (MDT) shares rose 0.1% to $102.97 as of November 17, 2026, a slight gain from the prior close of $102.88. BestStocks flagged the session as a material change for MDT. The move is tied to company news. Below, we break down what changed for MDT, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
Company News
Medtronic announced acquisition of Contego Medical to expand carotid artery disease treatment portfolio. Acquisition strengthens MDT's position in vascular intervention market and adds next-generation carotid therapies.
What it means for Medtronic Plc investors
For Medtronic Plc investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive 0.1% session move; Positive price momentum. Weighing against that: Medtronic plc (MDT) moved -5.11% from $83.57 to $79.30 on 2026-07-14; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $100.69, implying -2.2% downside from $102.97. BestStocks rates the overall signal quality weak (19/100). With earnings roughly 7 days out, the next report is the most likely near-term test of the move.
MDT price reaction
MDT last traded at $102.97, up $0.09 (+0.09%) from the previous close of $102.88. The session traded on 0.1× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $92.77 and $104.96, and it currently sits about 84% of the way up that band.
Bullish and bearish analyst opinions on Medtronic Plc (MDT)
The consensus analyst price target on Medtronic Plc (MDT) is $100.69, 2.2% below the recent $102.97. Over the past 90 days analysts logged 0 upgrades, 13 maintains, and 0 downgrades. Here is how the bullish and bearish cases on MDT line up.
The bullish case
- The Street's most bullish target is $120.00 (+16.5%).
- Positive 0.1% session move.
- Positive price momentum.
- Medtronic plc (MDT) moved +5.04% from $79.20 to $83.19 on 2026-07-02.
The bearish case
- The consensus analyst price target of $100.69 sits 2.2% below the recent $102.97, so the average target sees limited room to run.
- The most bearish analyst target is $83.00 (-19.4%).
- Medtronic plc (MDT) moved -5.11% from $83.57 to $79.30 on 2026-07-14.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Nov 17, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for MDT
In-depth MDT event analyses
Frequently asked questions about MDT
Why did Medtronic Plc (MDT) stock move?
Medtronic plc (MDT) rose 6.1% on November 4, 2026, closing at $104.96 versus $98.88 the prior session (close-to-close, from daily closes). Following completion of its MiniMed Split-Off and share retirement program, which retired approximately 55 million shares through an oversubscribed exchange offer without cash outlay (247wallst.com, Yahoo Finance). The move adds ~$6 billion to market value and structurally reduces share count to boost future EPS while refocusing the company on higher-margin core medical device business. Source: 247wallst.com.
How much did MDT stock rise?
MDT gained 0.09% ($0.09) versus the prior close of $102.88, last trading at $102.97 on 0.1× average volume.
When is Medtronic Plc's next earnings date?
MDT's next earnings report is estimated for 2026-11-24 — about 7 days away.
What is the analyst price target for MDT?
The consensus analyst price target for MDT is $100.69, about 2.2% below the current $102.97. Over the past 90 days, analysts recorded 0 upgrades, 13 maintains, and 0 downgrades.
How BestStocks tracks MDT
This page is generated automatically by BestStocks' change-detection system after company news was detected and verified against independent data sources. It draws on 20 tracked change events for MDT, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 17, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.
